Stay updated on POSEIDON Early Peanut OIT Clinical Trial
Sign up to get notified when there's something new on the POSEIDON Early Peanut OIT Clinical Trial page.

Latest updates to the POSEIDON Early Peanut OIT Clinical Trial page
- Check2 days agoChange DetectedThe record presents details of the completed Phase 3 POSEIDON study of AR101 peanut oral immunotherapy in children aged 1 to under 4, including eligibility, study sites, outcome measures, and a linked study protocol.SummaryDifference59%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner was added announcing updates to NIH websites and saying that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedRemoved a large block of Study Documents and related metadata from the study record, including the Study Protocol and Statistical Analysis Plan and sponsor-related entries. This affects access to documentation that helps interpret the study design and provenance.SummaryDifference18%

Stay in the know with updates to POSEIDON Early Peanut OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the POSEIDON Early Peanut OIT Clinical Trial page.